Thermo Fisher Scientific TMO today announced that it has signed an agreement to sell its
cell culture (sera and media), gene modulation and magnetic beads
businesses to GE Healthcare, a unit of General Electric Company GE, for approximately $1.06 billion. The businesses will become part of
GE Healthcare's Life Sciences division.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in